PDCD1 and neoplasm: Programmed cell death protein 1 (PD-1) or programmed cell death ligand 1(PD-L1) inhibitors can block the binding of PD-1 receptor protein on the surface of tumor cells with PD-1 receptor in T cells, thereby causing T cells to kill tumor cells [10,11].